Search research articles
Contact Us
Filters
Showing results (41-50 of 496) with videos related to
Page
of 50
Sort By:
Neuropharmacology
|
July 4, 2006
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin
Anne Dekeyne, Mark J Millan
Current Opinion in Pharmacology
|
November 10, 2009
Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance
Roberto Maggio, Mark J Millan
Therapie
|
August 23, 2008
Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) > D(2) antagonist, S33138
Mark J Millan, Mauricette Brocco
European Journal of Pharmacology
|
March 7, 2003
The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats
Françoise Lejeune, Mark J Millan
Behavioural Pharmacology
|
September 23, 2003
Discriminative stimulus properties of antidepressant agents: a review
A Dekeyne, M J Millan
European Journal of Pharmacology
|
February 21, 1994
The glycine B receptor partial agonist, (+)-HA966, enhances induction of antinociception by RP 67580 and CP-99,994
L Seguin, M J Millan
Neuropharmacology
|
March 1, 1990
Attenuation of opioid induced antinociception by 5-HT1A partial agonists in the rat
M J Millan, F C Colpaert
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
January 1, 1981
[Cytological and bacteriological examinations of the cervix and vagina. A review of the results obtained in a laboratory for analyses in Guadeloupe (author's transl)]
J Millan, O Crenn, E Lidome
Pharmacology, Biochemistry, and Behavior
|
July 16, 2011
Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms
Robert L Gannon, Mark J Millan
Drug Discovery Today
|
July 5, 2005
Dopamine D3 receptor antagonists as therapeutic agents
Jeffrey N Joyce, Mark J Millan
Page
of 50
Search research articles
Search
Showing results (41-50 of 496) with videos related to
Sort By:
Page
of 50
Neuropharmacology
|
July 4, 2006
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin
Anne Dekeyne, Mark J Millan
Current Opinion in Pharmacology
|
November 10, 2009
Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance
Roberto Maggio, Mark J Millan
Therapie
|
August 23, 2008
Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) > D(2) antagonist, S33138
Mark J Millan, Mauricette Brocco
European Journal of Pharmacology
|
March 7, 2003
The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats
Françoise Lejeune, Mark J Millan
Behavioural Pharmacology
|
September 23, 2003
Discriminative stimulus properties of antidepressant agents: a review
A Dekeyne, M J Millan
European Journal of Pharmacology
|
February 21, 1994
The glycine B receptor partial agonist, (+)-HA966, enhances induction of antinociception by RP 67580 and CP-99,994
L Seguin, M J Millan
Neuropharmacology
|
March 1, 1990
Attenuation of opioid induced antinociception by 5-HT1A partial agonists in the rat
M J Millan, F C Colpaert
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
January 1, 1981
[Cytological and bacteriological examinations of the cervix and vagina. A review of the results obtained in a laboratory for analyses in Guadeloupe (author's transl)]
J Millan, O Crenn, E Lidome
Pharmacology, Biochemistry, and Behavior
|
July 16, 2011
Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms
Robert L Gannon, Mark J Millan
Drug Discovery Today
|
July 5, 2005
Dopamine D3 receptor antagonists as therapeutic agents
Jeffrey N Joyce, Mark J Millan
Page
of 50